Dietary Supplement
oligofructose
oligofructose is a dietary supplement with 6 clinical trials. Historical success rate of 80.0%.
Total Trials
6
Max Phase
—
Type
DIETARY SUPPLEMENT
Molecule
—
Success Metrics
Clinical Success Rate
80.0%
Based on 4 completed trials
Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
25%(1 trials)
Terminated
1(17%)
Phase Distribution
Ph not_applicable
6
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution6 total trials
N/ANon-phased studies
6(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
80.0%
4 of 5 finished
Non-Completion Rate
20.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Active(1)
Completed(4)
Terminated(1)
Detailed Status
Completed4
Not yet recruiting1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
80.0%
Most Advanced
N/A
Trials by Phase
N/A6 (100.0%)
Trials by Status
not_yet_recruiting117%
completed467%
terminated117%
Recent Activity
0 active trials
Showing 5 of 6
not_yet_recruitingnot_applicable
Effect of Prebiotics in Saudi Adults With Type 2 Diabetes
NCT07464691
completednot_applicable
Effect of Oligofructose on Appetite in Overweight Subjects
NCT00912197
terminatednot_applicable
Campylobacter Enteritis and PI-BD: Dietary Reduction in Carbohydrates
NCT02232373
completednot_applicable
The Effect of the Low FODMAP Diet and Dietary Oligofructose on Gastrointestinal Form, Function and Microbiota
NCT02259465
completednot_applicable
The Effect of the Oligofructose Supplementation on Body Weight in Overweight and Obese Children
NCT01673152
Clinical Trials (6)
Showing 6 of 6 trials
NCT07464691Not Applicable
Effect of Prebiotics in Saudi Adults With Type 2 Diabetes
NCT00912197Not Applicable
Effect of Oligofructose on Appetite in Overweight Subjects
NCT02232373Not Applicable
Campylobacter Enteritis and PI-BD: Dietary Reduction in Carbohydrates
NCT02259465Not Applicable
The Effect of the Low FODMAP Diet and Dietary Oligofructose on Gastrointestinal Form, Function and Microbiota
NCT01673152Not Applicable
The Effect of the Oligofructose Supplementation on Body Weight in Overweight and Obese Children
NCT00522353Not Applicable
Prebiotic Fiber as a Modifier of Satiety Hormones and Body Weight in Overweight and Obese Adults
All 6 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 6